The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
Insulin therapy for diabetes mellitus is the most effective way to control glycemia with the progression of the disease and the ineffectiveness of other sugar-lowering drugs. At the same time, the existing limitations of traditional insulin preparations, along with increasing attention to the indivi...
Main Authors: | M. V. Shestakova, E. V. Surkova, A. A. Vachugova, I. A. Ipatko, E. E. Kazakova, I. A. Karpova, M. A. Kovarenko, L. P. Kolimbet, E. E. Krasilnikova, M. N. Kuzin, E. Y. Pashkova, M. I. Kharakhulakh, O. G. Tsygankova |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2021-07-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/12747 |
Similar Items
-
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01) -
Insulin degludec
by: Vishakha V Jain, et al.
Published: (2013-01-01) -
A review of the efficacy and safety of the finished fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes mellitus
by: A. S. Pogorelova
Published: (2018-07-01) -
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
by: Sanjay Kalra, et al.
Published: (2016-01-01) -
United States experience of insulin Degludec alone or in combination for type 1 and type 2 diabetes
by: Rendell M
Published: (2017-04-01)